Here, we provide an overview of research on the characterization of the regulation of the PI3K/AKT/PTEN signaling (Figure 1) at the viewpoint of pathogenesis for the NAFLD. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.